Showing results (911-920 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|January 20, 2021
Long noncoding RNA SNHG1 promotes human prostate cancer progression by sponging miR-383-5pGuangyi Huang, Xiao Guo, Hao YangAnti-Cancer Drugs|January 20, 2021
Circular RNA hsa_circ_0000554 promotes progression and elevates radioresistance through the miR-485-5p/fermitin family members 1 axis in esophageal cancerJianhua Wang, Yushan Chen, Rui Wu, et al.Anti-Cancer Drugs|October 1, 2019
Multiple systemic treatment options in a patient with malignant tenosynovial giant cell tumourSara Elena Rebuzzi, Massimiliano Grassi, Fabio Catalano, et al.Anti-Cancer Drugs|October 1, 2019
Pronounced clinical response following the oncolytic vaccinia virus GL-ONC1 and chemotherapy in a heavily pretreated ovarian cancer patientKristina M Mori, Peter D Giuliano, Katrina L Lopez, et al.Anti-Cancer Drugs|October 5, 2019
CUDC-101 overcomes arsenic trioxide resistance via caspase-dependent promyelocytic leukemia-retinoic acid receptor alpha degradation in acute promyelocytic leukemiaTianzhuo Zhang, Dan Ma, Danna Wei, et al.Anti-Cancer Drugs|September 11, 2019
A review of canakinumab and its therapeutic potential for non-small cell lung cancerKara M Schenk, Joshua E Reuss, Karin Choquette, et al.Anti-Cancer Drugs|September 14, 2019
Inhibition of laryngeal cancer stem cells by tetrandrineXiangyan Cui, Dong Xiao, Xin WangAnti-Cancer Drugs|September 14, 2019
MiR-342-3p inhibits cell migration and invasion through suppressing forkhead box protein Q1 in ovarian carcinomaChanghe Wang, Weimin Zhang, Shouli Xing, et al.Anti-Cancer Drugs|February 3, 2021
Rapid and exceptional response to Sonidegib in a patient with multiple locally advanced basal cell carcinomasVanessa Tarantino, Elisa Zavattaro, Federica Veronese, et al.Anti-Cancer Drugs|February 3, 2021
Sesamin induces cell cycle arrest and apoptosis through p38/C-Jun N-terminal kinase mitogen-activated protein kinase pathways in human colorectal cancer cellsXuxu Wang, Jiahao Qiao, Chaoyi Zou, et al.Pageof 464